| Date | Title | Description |
| 15.10.2025 | Tubulis Raises €308 Million Series C to Accelerate Clinical Development of Lead ADC Candidate TUB-040 and Expand Pipeline | • USD 361 million round represents the largest Series C for a European biotechnology company and the largest financing for a private ADC developer globally
• Round led by Venrock Healthcare Capital Partners with participation from other new... |
| 01.10.2025 | Sunrise Group: $29 Million Raised For Expanding Dreem Health | Sunrise Group, known as a leader in sleep health technology, has announced a funding round of $29 million dedicated to expanding Dreem Health, its innovative digital sleep clinic, to ensure its services reach all 50 states in the U.S. This ... |
| 25.09.2025 | Sunrise Group Raises $29M to Expand Dreem Health and Build the Largest U.S. Sleep Clinic | What You Should Know:
–Sunrise Group, a leader in sleep health technology, today announced a $29 million funding round to expand Dreem Health, its digital sleep clinic, across all 50 states.
– The round was led by Eurazeo, with participatio... |
| 23.09.2025 | +++ mymuesli-Mafia +++ Sentryc +++ Luqom Group +++ Calm/Storm +++ | Was gibt’s Neues? In unserem #StartupTicker liefern wir eine kompakte Übersicht über die wichtigsten Startup-Nachrichten des Tages (Dienstag, 23. September). #STARTUPLAND
SAVE THE DATE: Am 5. November findet unsere zweite STARTUPLAND statt.... |
| 03.05.2025 | Empowering Tomorrow: The Rise of Student-Led Initiatives at Oakridge International School | In the heart of Bengaluru, a revolution is brewing. Oakridge International School is redefining education through student-led initiatives. This isn’t just a school; it’s a launchpad for future leaders. Here, students are not mere recipients... |
| 29.04.2025 | French martech Reelevant secures €6M Series A for AI-driven personalisation | French martech startup Reelevant has raised €6M in Series A funding to fuel product development, talent acquisition, and international expansion. The round was led by Seventure Partners, with participation from Go Capital and several high-p... |
| 09.01.2025 | FIRE1: $120 Million Funding Raised For Transforming Heart Failure Care | FIRE1 – a leading connected medical device solutions company – announced the completion of a $120 million financing round to accelerate the company’s mission to transform the lives of millions of people living with heart failure. The fundin... |
| 08.01.2025 | FIRE1 Secures $120M for Heart Failure Management Platform | What You Should Know:
– FIRE1, a connected medical device company, announced it has secured $120M in funding to advance its mission to transform the lives of millions of people living with heart failure. The round was led by Polaris Partner... |
| 07.01.2025 | FIRE1 Secures $120M Financing | FIRE1, a Dublin, Ireland-based connected medical device solutions company, raised $120M in funding.
The round was led by Polaris Partners and Elevage Medical Technologies, joined by new investors Sands Capital and Longitude Capital, and exi... |
| 07.01.2025 | FIRE1 heats up with $120M for its heart failure monitor implant | Things are heating up for FIRE1, which posted a $120 million funding round to support its implant for tracking the hidden signs of heart failure.
The Dublin-based company also announced that the FDA has handed down a breakthrough designatio... |
| 10.12.2024 | Citryll's €85 Million Boost: A New Dawn for Inflammatory Disease Treatment | In the world of biotech, funding is the lifeblood. Recently, Dutch startup Citryll secured a significant €85 million in Series B funding. This financial windfall is not just a number; it represents hope for countless patients battling immun... |
| 09.12.2024 | Citryll Raises EUR 85M in Series B Funding | Citryll, an Oss, The Netherlands-based biotech company developing a new approach to treating immune-mediated inflammatory diseases by targeting Neutrophil Extracellular Traps (NETs), raised €85M in Series B funding.
The round was led by Joh... |
| 09.12.2024 | Oss-based Citryll secures €85 million Series B funding to advance NET-targeting therapy | Dutch startup Citryll, a biotech innovator in immune-mediated inflammatory diseases, has raised €85 million in a Series B funding round.
The financing was co-led by Johnson & Johnson Innovation (through its corporate venture capital org... |
| 20.06.2024 | YesWeHack Secures €26M in Series C Funding, Embarking on a New Chapter of Growth and Innovation | YesWeHack, a pioneering bug bounty and vulnerability management platform based in Paris, has successfully raised a substantial €26 million in Series C funding. This significant funding round was spearheaded by Wendel, a prominent investment... |
| 18.06.2024 | YesWeHack: Bug Bounty And Vulnerability Management Platform Closes €26 Million | YesWeHack, a global Bug Bounty and vulnerability management platform, announced a €26 million Series C funding round. Wendel led the round, which included new investors like Adelie and Seventure Partners and reinvestment from Bpifrance, Ope... |
| 13.07.2023 | Rostock-based insurtech hepster raises €10 million to focus on profitability and sustainable growth | German embedded insurtech hepster has raised €10 million in a Series B funding round. Via its API it enables companies 'to integrate needs-based and individual insurance into their offerings', including mobility, electronics, equipment, tra... |
| 17.03.2023 | AI-Powered Eyesight Correction Proves the Most Convincing to Investors as Unicorn CUP Finals Q1 2023 Conclude | Unicorn CUP Finals determined the final winner of Unicorn Battles Q1 2023 11 winning startups from industry-specific battles competed for the absolute winner’s title in two sessions The final winner is Soliddd and its AI-powered eyesight co... |
| 10.03.2023 | Winners of Unicorn Battles Q1 2023 Will Meet at the Unicorn CUP Finals | After nine industry-specific Unicorn Battles Q1 2023, Unicorn CUP Finals will take place on March 16th Nine winners of industry-specific Battles will compete for the title of the absolute winner The Finals will be divided into two sessions ... |
| 03.01.2023 | Parisian customer data company mediarithmics raises €7 million | Paris-based customer data platform mediarithmics has collected €7 million in its latest funding round, bringing its total investment to €20 million.
Founded in 2013 by its chief technology officer Stéphane Dugelay, the startup aspires to be... |
| 11.10.2022 | Clinical Microbiomics set to accelerate its expansion with EUR 10 million investment from Health for Life Capital™ II” managed by Seventure Partners | Seventure Partners, a worldwide leading microbiome venture capital, and Clinical Microbiomics A/S, a pioneering microbiome research company, today announced the completion of a... |
| 03.05.2022 | Tubulis Closes €60 Million Series B Financing to Accelerate its ADC Pipeline and Expand its Breadth of Platform Technologies | May 3, 2022 |
| 07.03.2022 | Tencent backs Cambridge-based startup in $67 million funding to address opportunities in biomedicine | Cambridge-based player in the field of microbiome-based therapeutics, biomarkers and targets, Microbiotica has raised £50 million ($67 million) funding. The Series B round was co-led by Flerie Invest and Tencent with participation from new ... |
| 05.05.2021 | Cytoki Pharma cierra una ronda de €38M liderada por Lundbeckfonden Emerge junto con Ysios Capital, Seventure Partners y +ND Capital | 05/05/2021
Nota de prensa
YSIOS CAPITAL INVIERTE EN CYTOKI PHARMA.
− La compañía biotecnológica Cytoki Pharma (Copenhague, Dinamarca) desarrolla nuevas proteínas basadas en interleuquina 22 (IL-22) para el tratamiento de lesiones epiteli... |
| 05.05.2021 | Cytoki Pharma secures $45M Series A round lead by Lundbeckfonden Emerge together with Ysios, Seventure Partners and +ND Capital | 05/05/2021
Press release
CYTOKI PHARMA RAISES $45 MILLION SERIES A FINANCING.
Proceeds to support the development of its lead program (lipidated IL-22) through clinical proof of concept in Inflammatory Bowel Disease and explore expansion... |
| 30.04.2021 | Parisian automated spend management solution Expensya raises $20 million | Expensya, the Paris-based automated spend management solution for businesses has raised $20 million.
The financing was supported by MAIF Avenir and Silicon Badia with existing investors ISAI and Seventure also contributing.
The fresh fundin... |
| 29.03.2021 | Seventure Partners: New Report Reveals Links Between Covid-19 and the Microbiome | Seventure Partners, one of Europe’s leaders in financing innovation and a world leader in life science microbiome investment, has published an analysis highlighting the close links between Covid-19 and the individual’s microbiome.
The repor... |
| 05.03.2021 | German company Hepster secures US $10 million in Series A funding | Hepster, a German company providing innovative insurance services, has announced early in March 2021 that it has raised USD 10 million in its Series A funding round. The round was led by Element Ventures along with participation from Sevent... |
| 13.01.2021 | ‘Significant interest’: Venture capital major Seventure Partners extends €200m+ microbiome fund | European life sciences investment firm Seventure Partners has extended the final close of its second microbiome innovation fund and increased focus on advances in the skin... |
| 07.10.2020 | Hydration company LARQ bags USD 10 million in Series A funding | The San Francisco Company LARQ announced receiving US$ 10 million Series-A funding on 29th September 2020 led by Seventure, including the participation of DCM Ventures. The company will utilize the funding amount to expand globally by 2021 ... |
| 12.03.2020 | Precision biologics: the key to reducing antibiotic use in livestock? | Pathogens, as is clear to anyone tracking the outbreak of Covid-19 on humans or African Swine Fever on pigs, can inflict disastrously global impacts on public health, as well as wreaking havoc on vital food supply chains. To date, preventin... |
| 16.10.2019 | French poultry tech startup Tibot Technologies raises €3m seed round for health-boosting robot | When it comes to agtech impacting animal agriculture, we’ve written about IoT technology to track livestock, imaging to test for mastitis in dairy cows, computer vision technology to recognize each cow by her face, and giant digesters to co... |
| 06.03.2019 | Health for Life Capital II Launches €200M Microbiome-Focused Fund | Seventure Partners, a Paris, France-based life science microbiome investment firm, completed the first closing of its second dedicated fund.
Backers included returing investors such as Danone, Novartis, Lesaffre, Tornier, Unigrains and Bel,... |
| 21.03.2018 | Seventure Partners and Adisseo Launch €24m Livestock Tech Fund | Seventure Partners, a French venture capital firm focused on life sciences, has launched AVF, a new €24m ($29.4m) venture capital fund directed at companies focusing on the field of animal health, feed, and nutrition. Adisseo, an industry l... |
| 21.03.2018 | Adisseo and Seventure Partners Launch Fund for Innovative Animal Health and Nutrition | Seventure Partners, a European Life science microbiome investment firm, has launched AVF, an innovative venture capital fund, targeted at supporting companies in the field of animal health, feed and nutrition.
The first close of AVF at €24m... |
| 22.01.2018 | Zipongo raises $18M to bring food prescription app for chronic conditions to providers, health plans | The FoodScripts app is geared to people with hypertension, diabetes, obesity and other conditions. It provides nutrition programs that adhere to their dietary needs, according to the press release.
In response to emailed questions, Zipongo ... |
| 14.11.2017 | Scipio bioscience announces its seed funding of €1.2m obtained from Seventure Partners’ Quadrivium I seed fund and High-Tech Gründerfonds | Scipio bioscience, a Paris-based biotechnology company devoted to providing a novel sample preparation solution for single-cell studies in the form of benchtop kits, announces... |
| 26.09.2017 | French biotech company Eligo raises $20 million in Series A funding | Eligo Bioscience, a biotech company based in France, has raised a $20 million Series A round from Khosla Ventures and Seventure Partners together with a $2 million award from Worldwide Innovation Challenge.
Eligo is developing a biotherapeu... |
| 06.07.2017 | Seventure’s Health for Life Capital™ participates in $26.1m financing of Europe’s largest digital health provider, Push Doctor | Europe’s largest digital health provider, Push Doctor, announces that it has raised $26.1M in a Series B funding round led by Accelerated Digital Ventures (“ADV” – the... |
| 31.01.2017 | CryoCapCell Raises €1.5M in Funding | CryoCapCell, a Paris, France-based company that develops and markets technologies for high-pressure vitrification, raised €1.5m in funding.
The Quadrivium 1 seed capital fund, managed by Seventure Partners, made the investment.
The company ... |
| 23.01.2017 | Personal MedSystems raises €5 million for its CardioSecur platform | Personal MedSystems, the German company behind mobile ECG test CardioSecur, has raised a Series B round of €5 million.
New investors in the round include KPN Ventures, Sino-German High-Tech Fund (a joint fund supported by China’s Donghai Se... |
| 30.08.2016 | Mint Solutions Raises healthy €5M Series B investment to Revolutionize Medication Safety | Dutch-Icelandic medical startup Mint Solutions Holding BV has found the right medicine to cure its funding woes in the form of a € 5 million Series B equity funding round investment . The healthy donors are led by the Brabant Development Ag... |
| 29.04.2016 | Daily funding roundup - April 29, 2016 | Mercato led investment in Stance; GotIt! recieved over $9M; VividCortex raised $4.5M Series A
OMERS Ventures made an undisclosed investment in Digital Currency Group (DCG), a New York-based builder, incubator and funder of bitcoin and block... |
| 12.02.2016 | MilliDrop Raises €1M in Funding | MilliDrop, a Paris, France-based designer and developer of cell culture machines based on millifluidics technology for bacteriological research and diagnosis purposes, raised €1m in funding.
Seventure Partners‘s Quadrivium 1 seed fund made ... |
| 12.02.2016 | Daily funding roundup - February 12, 2016 | payleven received $10M; RKSV raised $4M; Jisto closed a $2.45M Seed funding
LetterOne, a Luxembourg-based private equity and venture capital firm headed by Mikhail Fridman, invested $200 million in Uber. This new investment is a drop in the... |
| 11.02.2016 | Mobile Payments Startup Payleven Raises Another $10M | The days of Square clones popping up, everywhere you looked and capitalizing on Square’s conservative approach to global expansion, are long gone. But those startups are not. And today, one of them is announcing a Series D round.
Payleven, ... |
| 14.12.2015 | Seventure Partners Completes New Closing for Microbiome Fund, which now totals €160M | Paris, France-based venture capital firm Seventure Partners completed a new closing for its microbiome fund, which now totals €160m.
Health for Life Capital, which aims to anticipate the microbiome revolution in the fields of health and nut... |
| 16.10.2015 | Daily funding roundup: October 16, 2015 | MycoTechnology closed $9.2M round; Mast received $7M; HRBoss landed $2M
Entrenar.me, a Valencia, Spain-based platform that connects people to personal trainers, closed a €205,000 ($233,700) funding round. The round was led by SeedSyndicates... |
| 15.07.2015 | Daily funding roundup - July 15, 2015 | Credit Benchmark raised $20M; Zesty landed $17M; Aveni secured $13.5M
Virtuous Software LLC, an enterprise generosity platform raised $700,000 in seed funding to further its customer relationship management software, which helps nonprofits ... |
| 27.04.2015 | PEP-Therapy Raises €1.3M in Funding | PEP-Therapy, a Paris, France-based biotechnology company developing targeted therapies for cancer treatments, raised €1.3m in funding.
Backers included the Quadrivium 1 seed fund managed by Seventure Partners, for €1m, supplemented by a per... |
| 09.01.2015 | Seventure invests EUR 1 M (USD 1.25 M) in First Investment Round for MaaT Pharma™ | Seventure Partners, one of Europe’s leaders in financing innovation, announces today its investment in MaaT Pharma™, a newly founded French microbiome company. Seventure... |
| 28.08.2014 | MinuteBuzz Raises €1M in Funding | MinuteBuzz, a French entertainment media company, raised €1m in funding.
The round was led by Seventure Partners, which became a minority shareholder.
The company intends to use the funds to continue its investment in innovative formats wit... |
| 08.07.2014 | Mint Solutions Secures €4.425M in Series A Financing | Mint Solutions, an Amsterdam, the Netherlands-based developer of a platform which helps patients get the right medication at the right time, secured €4.425m in Series A financing.
Backers included Life Sciences Partners and Seventure Partne... |
| 01.05.2014 | Enterome Bioscience Raises €10M in Series B Funding | Enterome Bioscience SA, a Paris, France-based developer of innovative disease management solutions based on understanding of the gut microbiome, raised €10m in the first tranche of a Series B funding.
The round was led by existing investors... |
| 24.04.2013 | Personal MedSystems Raises €2.5M in Series A Financing | Personal MedSystems GmbH, a Berlin and Frankfurt am Main, Germany-based company that develops products and services for mobile healthcare, raised €2.5m in Series A financing.
The backer was Seventure Partners.
The company intends to use the... |
| 27.02.2013 | Recommerce Solutions Raises €7.1M in Funding | Recommerce Solutions, a French provider of technology and sustainable services, raised €7.1m in funding.
Backers included Seventure Partners, CDC Entreprises (FSN PME), and 3T Capital.
The company intends to use the capital for internationa... |
| 26.11.2012 | TxCell Raises €12.4M in Third Financing | TxCell SA, a France-based biotechnology company developing cell-based immunotherapies for the treatment of severe chronic inflammatory diseases, raised €12.4m in a third financing.
Backers include the InnoBio fund, managed by CDC Entreprise... |
| 01.10.2012 | Biophytis Closes €2M Series B Financing | Biophytis, a Romainville (Seine-Saint-Denis), near Paris-based research company in health and nutrition focusing on metabolic disorders and age-related diseases, has raised €2m (approximately $2.6m) in Series B funding round.
Metabrain Rese... |
| 17.07.2012 | Domain Therapeutics Closes €2M Funding | Domain Therapeutics, a Strasbourg, France-based biopharmaceutical company dedicated to the discovery and early development of small molecules targeting G-Protein Coupled Receptors (GPCRs), has completed a €2m financing.
Half of the funds ha... |
| 07.06.2012 | ProTip Closes $4.7M Financing | ProTip SA, a Strasbourg, France-based emerging medical device company, has raised $4.7m in Series C financing (approximately €3.8m).
The round was led by new investor Seventure, with participation from existing investors Fonds Lorrain des M... |
| 12.04.2012 | Les Laboratoires Nutrition & Cardiometabolism Completes €3.5M Second Funding Round | Les Laboratoires Nutrition & Cardiometabolism (LNC), a Bordeaux, France-based expert in medical nutrition and metabolic diseases, completed a €3.5m second funding round.
The round was led by Seventure Partners, with participation from I... |
| 23.03.2012 | Enterome Raises €5M in Series A Funding | Enterome, a Paris, France-based a stratified medicine company developing biomarkers for chronic and challenging medical conditions relating to abnormalities of bacterial composition of the human intestine (metabolic and bowel diseases), has... |
| 09.12.2011 | Mootwin Raises €4M in Second Funding Round | Mootwin, a Grenoble, France-based company specialized in real time applications for smartphone, recently raised €4m in a second funding round.
Backers include Naxicap Partners Création and Seventure Partners.
The company is using the capita... |
| 01.12.2011 | arGEN-X Closes €27.5M Series B Funding Round | arGEN-X, a Rotterdam, The Nederlands-based biopharmaceutical company focused on the discovery and development of human monoclonal antibodies, closed a €27.5m (US$37m) Series B funding.
The round was co-led by OrbiMed Advisors and Seventure ... |
| 06.05.2011 | Tigerlily Completes €900K Funding Round | Tigerlily SAS, a Paris, France-based provider of social marketing solutions, completed a €900k funding round.
Investors include Seventure Partners and Seed4Soft. They joined initial backer Boulas Ventures.
The company intends to use the fun... |
| 03.05.2011 | Tigerlily raises $1.3 million (€900K) to help brands avoid Nestle-like Fan page disasters | Recently, Paris-based Tigerlily seemed like it was slipping under the radar. It’d been a while since we’d heard anything from the company that we suggested Nestlé take a look at when the brand came under fire on social media platforms last ... |
| 12.08.2010 | Corsican Startups are Napoleon Dynamite | Like New Hope, Pennsylvania, Corsica is most definitely not the first place that comes to mind when we talk about tech and innovation. For the geographically challenged, I should clarify that we’re talking about that island off the southern... |
| 15.04.2010 | PhosphonicS Raises £3.5M in Second Round of Financing | PhosphonicS, a London-based company deploying novel technology to recover precious metals such as platinum, rhodium and palladium from process, waste and effluent streams, has secured £3.5m (approximately $5.75m) in a second financing round... |
| 05.10.2009 | TalentSoft secures €1.6 million in VC for its HR software | [FRANCE] TalentSoft, a French software startup which has SAAS software enterprise products has finalised a new round of funding with Seventure Partners to the tune of €1.6 million. The idea is to further develop its products which are desig... |
| 20.07.2009 | BiancaMed receives additional €6 million funding | BiancaMed announced today that it has received an additional €6 million funding.
This new capital will allow the company to expand its core team, accelerate the launch of several innovative consumer products with existing ‘go-to-market’ par... |
| 20.07.2009 | Sleep monitoring start-up scoops up $9.8M in VC | BiancaMed, a Dublin, Ireland-based developer of monitoring technology for sleep apnea diagnosis and other sleep or breathing related conditions, has raised €6 million ($9.8 million) in its second round of venture capital. The company's tech... |
| - | Abalos Therapeutics Completes Series A Extension Bringing Total Raised to EUR 43 Million | October 14, 2021 |
| - | Scipio bioscience raises €6.0 M Series A financing to develop and launch a kit dedicated to sample preparation for single-cell RNA-sequencing | Scipio bioscience, a Paris-based biotechnology company, developing a new generation of single-cell sequencing solutions, announces today that it has secured a €6.0 M Series A financing from an international syndicate led by M Ventures (Amst... |
| - | Tencent backs Cambridge-based startup in $67 million funding to address opportunities in biomedicine | Cambridge-based player in the field of microbiome-based therapeutics, biomarkers and targets, Microbiotica has raised £50 million ($67 million) funding. The Series B round was co-led by Flerie Invest and Tencent with participation from new ... |
| - | Zipongo raises $18M to bring food prescription app for chronic conditions to providers, health plans | Zipongo, a digital nutrition program founded in 2011, developed an app to make personalized meal recommendations based on dietary needs. Although its initial focus was on corporate wellness plans, it is expanding into other areas of healthc... |
| - | Parisian automated spend management solution Expensya raises $20 million | Expensya, the Paris-based automated spend management solution for businesses has raised $20 million.
The financing was supported by MAIF Avenir and Silicon Badia with existing investors ISAI and Seventure also contributing.
The fresh fundin... |
| - | Tubulis Raises €10.7 M Series A to Advance Development of a New Generation of Antibody-Drug Conjugates | Tubulis today announced the close of a €10.7 million Series A financing round to accelerate the development of a new class of highly stable and efficient antibody-drug conjugates (ADCs) and to support the further growth of the company. The ... |
